In cases where eGFR estimates differ significantly, or where precision is essential for clinical decision-making (e.g., CKD staging, drug dosing, referral timing), the combined creatinine–cystatin C equation (CKD-EPI 2021) demonstrated improved concordance with clinical diagnoses in this cohort. This evidence concerns the gene CST3 and chronic kidney disease.